WATSON 526 (Mononessa ethinyl estradiol 0.035 mg / norgestimate 0.25 mg)
Generic Name: ethinyl estradiol/norgestimate
This pill with imprint "WATSON 526" is Blue, Round and has been identified as Mononessa ethinyl estradiol 0.035 mg / norgestimate 0.25 mg. It is manufactured by Watson Pharmaceuticals.
Mononessa is used in the treatment of birth control; ovarian cysts; abnormal uterine bleeding; endometriosis; gonadotropin inhibition and belongs to the drug class contraceptives. Not for use in pregnancy. Mononessa ethinyl estradiol 0.035 mg / norgestimate 0.25 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- ethinyl estradiol/norgestimate
- WATSON 526
- ethinyl estradiol 0.035 mg / norgestimate 0.25 mg
- Prescription only
- Drug Class:
- Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- Not a controlled drug
- Watson Pharmaceuticals
- National Drug Code (NDC):
More about Mononessa (ethinyl estradiol / norgestimate)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 175 Reviews – Add your own review/rating
- Drug class: contraceptives
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.